Homologous recombination deficiency and glycolysis-related pathway in adjuvant chemotherapy for triple-negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial.

Zhu, Si-Yuan; Ma, Ding; Ye, Fu-Gui; Shao, Zhi-Ming; Yu, Ke-Da

Zhu, Si-Yuan; Ma, Ding; Ye, Fu-Gui; Shao, Zhi-Ming; Yu, Ke-Da.

Affiliation

Zhu SY; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Ma D; Shanghai Medical College, Fudan University, Shanghai, China.
Ye FG; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Shao ZM; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Yu KD; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

Clin Transl Med ; 11(9): e513, 2021 09.

Article in En | MEDLINE | ID: mdl-34586725

Subject(s)

Biomarkers, Tumor/genetics; Glycolysis/genetics; Homologous Recombination/genetics; Triple Negative Breast Neoplasms; Biomarkers, Tumor/metabolism; Chemotherapy, Adjuvant; Female; Genomics; Humans; Middle Aged; Randomized Controlled Trials as Topic; Triple Negative Breast Neoplasms/drug therapy; Triple Negative Breast Neoplasms/genetics; Triple Negative Breast Neoplasms/metabolism; Triple Negative Breast Neoplasms/mortality

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Biomarkers, Tumor / Homologous Recombination / Triple Negative Breast Neoplasms / Glycolysis Type of study: Clinical_trials Limits: Female / Humans / Middle aged Language: En Journal: Clin Transl Med Year: 2021 Document type: Article

Fulltext

XML

PubMed Links

Search on Google